Clinical Trial Update: Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple Myeloma [NA]

View source ↗

Summary

This completed clinical trial evaluated lenalidomide plus azacitidine as adaptive immunotherapy before autologous stem cell transplantation in multiple myeloma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Revlimid (lenalidomide)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Multiple Myeloma | NA | Status: COMPLETED | Results posted: 2015-10-05